What is 688331.SS's gross margin?

RemeGen (688331.SS) has a gross margin of 97% and a net margin of 83%.

What is 688331.SS's P/E ratio?

688331.SS's P/E ratio is 11.3 with ROE of 109%.

Where can I see 688331.SS's full financials?

See RemeGen (688331.SS) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

RemeGen (688331.SS) Financials — Revenue, Earnings, Cash Flow

¥117.34 ($17.50)

+0.67 (+0.57%)

SHH · Healthcare · Biotechnology · Tech Score Sell · Power 42 · ¥64.9B mcap · 463M float · 1.99% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ETF Exposure

📊 Key Metrics

TTM

¥8B

Revenue

+286.2% YoY

¥6B

Net Income

+611.7% YoY

¥4B

Free Cash Flow

+658.2% YoY

96.5%

Gross Margin

84.4%

Op. Margin

83.4%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE109.1%

ROA74.2%

ROIC140.3%

Valuation

P/E11.3

P/B7.9

EV/EBITDA11.2

Leverage

Debt/Equity0.04

Current Ratio4.86

Interest Cov.128.6x

Quality Scores

Piotroski F7/9

Altman Z33.92

Beneish M4.50